Powles, Thomas <br/><br/>
The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.  [electronic resource] 

 -  European urology  Sep 2011 
 - 448-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7560 
<br/><br/><label>Standard No.: </label>10.1016/j.eururo.2011.05.028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Carcinoma, Renal Cell--drug therapy<br/>Chemotherapy, Adjuvant<br/>Clinical Trials, Phase II as Topic<br/>Disease Progression<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Indoles--administration & dosage<br/>Kaplan-Meier Estimate<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Nephrectomy--adverse effects<br/>Patient Selection<br/>Proportional Hazards Models<br/>Prospective Studies<br/>Protein Kinase Inhibitors--administration & dosage<br/>Pyrroles--administration & dosage<br/>Risk Assessment<br/>Risk Factors<br/>Sunitinib<br/>Survival Rate<br/>Time Factors<br/>Treatment Outcome